Schonfeld Strategic Advisors’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
NTCM
RIM
RHJA
RCMC
SCM
MIP
Schonfeld Strategic Advisors's IRMD Position: Q3 2020 in Review
Schonfeld Strategic Advisors sold out of iRadimed (IRMD) in Q3 2020, closing a stake of 11,883 shares — an estimated $276K sold.
Schonfeld Strategic Advisors first reported a position in IRMD in Q2 2020 and held it in 1 quarter. The position peaked at $276K in Q2 2020. 62 funds tracked by Wall St. Rank hold IRMD as of Q3 2020.
- Schonfeld Strategic Advisors reported no remaining iRadimed position as of Q3 2020 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 11,883 iRadimed shares in Q3 2020, an estimated $276K.
- Schonfeld Strategic Advisors first reported a position in iRadimed in Q2 2020 and held it in 1 quarter.
- Schonfeld Strategic Advisors's iRadimed position peaked at $276K in Q2 2020.
- 62 funds tracked by Wall St. Rank held iRadimed as of Q3 2020.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.